Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.4 (
deaminase
)
5,113
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The enzyme N-acetylmuramyl-L-alanine amidase (mucopeptide
amidohydrolase
, EC 3.5.1.28) has been detected in human, mouse, rabbit, bovine and sheep sera. A method for detection of
amidase
activity using [14C]peptidoglycan monomer as the substrate has been developed. Partial purification of human and mouse
amidase
was achieved by gel chromatography on Bio-Gel
A-1
.5 m, DEAE-Sephadex A-50 and Sephadex G-100. Both
amidase
preparations exhibited maximal activity at pH 9.0 in Tris-HCl buffer and required Mg2+ for maximal activity. Following digestion of peptidoglycan monomer, GlcNAc-MurNAc-L-Ala-D-isoglutaminyl-meso-diaminopimelyl-D-Ala-D-Ala, the disaccharide GlcNAc-MurNAc and the corresponding pentapeptide L-Ala-D-isoglutaminyl-meso-diaminopimelyl-D-Ala-D-Ala were formed and subsequently isolated and chemically characterized. The enzyme therefore acts as an N-acetylmuramyl-L-alanine amidase by cleaving the bond between N-acetylmuramic acid and L-alanine. The glycan linked, peptide-not-cross-linked peptidoglycan dimer was also shown to be a substrate for human and mouse
amidase
.
...
PMID:Partial purification and characterization of N-acetylmuramyl-L-alanine amidase from human and mouse serum. 612 7